COVALENT BIOSCIENCE, INC.

Basic Information

8285 EL RIO ST, STE 150
HOUSTON, TX, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 965999738
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Covalent Vaccine for HIV

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): We propose a Phase I STTR study to develop a novel human immunodeficiency virus (HIV) vaccine strategy with the potential of world-wide efficacy. The HIV/AIDS pand ...

    STTR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government